Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2019 046 664.1 |
96 | EP file number | EAKZ | 19 85 6433.8 |
86 | WO file number | WAKZ | PCT/US2019/049384 |
97 | EP publication number | EPN | 3843759 |
87 | WO publication number | WPN | 2020096682 |
54 | Designation/title | TI | VERWENDUNG VON VON TUMORINFILTRIERENDEN LYMPHOZYTEN ZUR BEHANDLUNG VON NSCLC PATIENTEN DIE GEGEN ANTI-PD1 ANTIKÖRPERTHERAPIE RESISTENT SIND |
51 | IPC main class | ICM (ICMV) | A61K 35/17 (2025.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 45/06 (2006.01), C12N 5/0781 (2010.01), C12N 5/0783 (2010.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Sep 3, 2019 |
96 | EP application date | EAT | Sep 3, 2019 |
86 | WO application date | WAT | Sep 3, 2019 |
43 | Date of first publication | OT | May 14, 2020 |
| Date of publication of grant | PET | Feb 14, 2024 |
71/73 | Applicant/owner | INH | Iovance Biotherapeutics, Inc., San Carlos, CA, US |
72 | Inventor | IN | Fardis, Maria, San Carlos, CA 94070, US; NATARAJAN, Arvind, Basking Ridge, NJ 07920, US |
74 | Representative | VTR | Hernandez, Yorck, Dipl.-Ing., 82031 Grünwald, DE |
| Address for service | | HERNANDEZ IP, 82031 Grünwald, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201862725976 P Aug 31, 2018
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201862726919 P Sep 4, 2018
|
| Due date | FT FG | Sep 30, 2025 Annual fee for the 7th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003843759A2 Searchable text:
EP000003843759A2 Original document:
EP000003843759B1 Searchable text:
EP000003843759B1 Original document:
WO002020096682 Searchable text:
WO002020096682 |
43 | Date of first publication | EVT | May 14, 2020 |
| Date of the first transfer into DPMAregister | EREGT | Jul 7, 2021 |
| Date of the (most recent) update in DPMAregister | REGT | May 8, 2025 (Show all update days)(Hide all update days)- May 8, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 14.02.2024: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 14.02.2024: deleted
- Feb 6, 2025
- Procedures: Procedure relating to EP application, Grant has become final, 15.11.2024: changed
- Jan 2, 2025
- IPC main class: changed
- Procedures: Change of classification, Change of IPC main class, 09.11.2023: changed
- Procedures: Procedure relating to EP application, Grant has become final, 15.11.2024: new
- Oct 31, 2024
- St.36: changed (technical change)
- Oct 2, 2024
- Jul 25, 2024
- St.36: changed (technical change)
- May 9, 2024; May 8, 2024; Feb 22, 2024; Jan 26, 2024; Jan 25, 2024; Nov 16, 2023
- Historical data not available for this/these date(s)
- Jul 7, 2021
- Date of the first transfer into DPMAregister
|